Clinical trial
A Randomized,Double Blind,Placebo Parallel Controlled,Multicenter Clinical Sthdy of Ginkgo Diterpene Lactone Meglumine Injection for Acute Ischemic Stroke Efficacy Safety.
NCT02526225 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized,Double Blind,Placebo Parallel Controlled,Multicenter Clinical Sthdy of Ginkgo Diterpene Lactone Meglumine Injection for Acute Ischemic Stroke Efficacy Safety.
- Lead sponsor
- Beijing Tiantan Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 1, 2016
- Completion date
- August 31, 2019
- Enrollment
- 3,452 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.